Carrageenin-induced experimental pneumonia in rats.
The authors verified the possibility of modelling pneumonia by the intratracheal administration of carrageenin solution into the lungs of rats. The most satisfactory dose was found to be 0.5 ml 0.7% carrageenin solution administered at 40 degrees C. The disease, evaluated by the morphological and functional signs, culminated after two days. Both macroscopically and histologically the lungs displayed typical signs of catarrhal suppurative aspiration bronchopneumonia. Functionally, marked tachypnoea (mean 180 cycles/min as against 110 c/min in the conscious controls) and raised functional residual capacity were found. A drop in the respiration rate and in FRC after bilateral cervical vagotomy indicated that a reflex component participates in the origin of the above two signs.
D000403:Airway Resistance; D000818:Animals; D001996:Bronchopneumonia / Q000503:physiopathology; D002351:Carrageenan / Q000008:administration & dosage; D004195:Disease Models, Animal; D008170:Lung Compliance; D008297:Male; D008465:Mechanoreceptors / Q000503:physiopathology; D011014:Pneumonia / Q000139:chemically induced / Q000503:physiopathology*; D051381:Rats; D012115:Residual Volume; D013990:Tidal Volume; D014797:Vital Capacity; D014939:Work of Breathing
D002351:Carrageenan